The sanctions recommended Dec. 4 against plaintiffs firm Hagens Berman Sobol Shapiro over its pursuit of three thalidomide cases has plaintiffs lawyers pointing out the difficulty in immediately assessing the viability of products liability mass tort cases and defense lawyers warning plaintiffs counsel to be honest with themselves.
The special discovery master appointed to weigh in on issues in what was once 52 thalidomide cases filed in the Eastern District of Pennsylvania said Hagens Berman engaged in “bad-faith advocacy” for three of the claims it ultimately withdrew after in-depth discovery.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
